PPBT
Purple Biotech
PPBT
PPBT
30 hedge funds and large institutions have $5.52M invested in Purple Biotech in 2020 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
0.06% less ownership
Funds ownership: 0.08% → 0.02% (-0.06%)
Holders
30
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$400K | |
| 2 | +$281K | |
| 3 | +$262K | |
| 4 |
ECM
ETrade Capital Management
Arlington,
Virginia
|
+$135K |
| 5 |
JPMPWA
J.P. Morgan Private Wealth Advisors
San Francisco,
California
|
+$56K |
Top Sellers
| 1 | -$619K | |
| 2 | -$605K | |
| 3 | -$145K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$140K |
| 5 |
Renaissance Technologies
New York
|
-$116K |